340binformed.org

Your Free Source for 340B News and Commentary

  • About us
  • Advertise
  • Contact
  • 340B Health

Record Breaking 49 Orphan Drugs Approved in 2014

New filing by PhRMA in 340B lawsuit is due by Feb. 25 

February 19, 2015—In another sign of orphan drugs' rising prominence in drugmakers' portfolios, an industry blog reports that the Food and Drug Administration approved 53 percent more orphan products in 2014 than in 2013.   … [Read more...]

More Details Emerge on 340B Audit of Drug Manufacturer

Fairness of allocation procedures also being examined 

February 12, 2015—More information about the first 340B program audit of a drug manufacturer emerged today during a drug industry government pricing conference in Washington. … [Read more...]

Hospitals Back HHS in 340B Orphan Drug Lawsuit

Groups file briefs defending HRSA's interpretive rule 

February 11, 2015—Hospital groups have asked a federal district judge to dismiss the drug industry's lawsuit challenging the 340B orphan drug exclusion interpretive rule. … [Read more...]

340B Omnibus Guidance Slated for June Release

Regulations coming on manufacturer penalties, ceiling prices, and dispute resolution 

February 5, 2015—The Health Resources and Services Administration plans in June to issue wide-ranging 340B program guidance on patient definition and other issues over which it lacks clear authority to regulate, the head of HRSA's Office of Pharmacy Affairs said today. … [Read more...]

HRSA Names Drugmakers Not Following 340B Orphan Drug Rule

Says purpose is to enable states to collect Medicaid rebates 

February 5, 2015—The Health Resources and Services Administration today identified 13 drug companies that are not complying with its 340B orphan drug exclusion interpretive rule. … [Read more...]

President Seeks $24.73 Million for 340B Oversight and Operations

Patient definition and hospital eligibility guidance "to be finalized" in fiscal year 2016 

February 2, 2015—The Obama administration is seeking $24.73 million to run the 340B drug discount program in the fiscal year that begins in October – more than double this year's funding level. The request came in the proposed fiscal year 2016 budget that the President sent to Congress today.    … [Read more...]

Celgene Posts Notice on 340B Program Website

Explains why it stopped adding 340B and other providers to limited distribution networks 

January 30, 2015—The biotech company Celgene, acting at the request of the Health Resources and Services Administration, has posted a notice on the 340B program website explaining why it has stopped adding providers to its limited distribution networks for three of its products, including its top-selling blood cancer drug Revlimid.      … [Read more...]

« Previous Page
Next Page »

LATEST ARTICLES DELIVERED

Get new article alerts via email.

This field is required.

Check your inbox or spam folder now to confirm your subscription.

FOLLOW | SHARE | LIKE

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

340B Health Twitter

Twitter feed is not available at the moment.

RSS feed: 340B Employed 340B Employed

  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Specialist | Vail Health November 17, 2026
  • Pharmacy Manager, 340B Program | Tufts Medical Center November 11, 2026
  • 340B Program Pharmacy Manager | Allies for Health + Wellbeing November 10, 2026

Copyright © 2026 · 340B Health